China Cord Blood Corp. (NYSE:CO) dropped 1.1% during mid-day trading on Tuesday . The company traded as low as $5.20 and last traded at $5.20, with a volume of 56,565 shares changing hands. The stock had previously closed at $5.26.

CO has been the subject of a number of recent research reports. Zacks Investment Research lowered shares of China Cord Blood Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, July 19th. TheStreet lowered shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Five analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. China Cord Blood Corp. has a consensus rating of “Hold” and a consensus target price of $6.75.

The company has a market capitalization of $416.43 million and a P/E ratio of 27.81. The stock has a 50 day moving average price of $5.36 and a 200 day moving average price of $5.85.

China Cord Blood Corp. (NYSE:CO) last issued its quarterly earnings results on Monday, August 22nd. The company reported $0.03 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.03. The firm had revenue of $26 million for the quarter, compared to analysts’ expectations of $26.23 million. Analysts anticipate that China Cord Blood Corp. will post $0.17 EPS for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.